Literature DB >> 8890034

Evaluation of virological procedures to detect fetal human cytomegalovirus infection: avidity of IgG antibodies, virus detection in amniotic fluid and maternal serum.

G Ruellan-Eugene1, P Barjot, M Campet, A Vabret, M Herlicoviez, G Muller, G Levy, B Guillois, F Freymuth.   

Abstract

Human cytomegalovirus (HCMV) is the most common cause of viral intrauterine infection and fetal damage largely due to maternal primary infection. Virological procedures which are able to detect HCMV fetal infection were evaluated. HCMV IgG antibodies were detected in 62.5% of the pregnant women and 1.47% had a primary infection. From March, 1992 to August, 1995, 29 seroconversions were observed, and in 64 other cases. HCMV IgM antibodies were detected in the first serological test. The mean IgG antibody avidity test (AI) was 31% for the 11 seroconversions tested and 74% in 32 cases where IgG and IgM HCMV antibodies were detected in the first serum. In the 29 HCMV seroconversions, 19 amniocentesis were carried out and 12 fetuses (41.4%) were infected in utero. In four amniotic fluids positive in culture and PCR, the fetus or newborns were infected and in one out of the two cordocentesis undertaken, hepatitis, anemia, and thrombocytopenia were noted. In four other cases, investigations seeking HCMV in amniotic fluid were negative whereas infants were infected at birth. Among the 64 cases with positive HCMV IgM and IgG antibodies detected in the first serological test, three fetuses were infected in utero, but no amniotic fluid was available in these cases. Amniotic fluids were studied in 39 cases, and HCMV detection by culture and PCR-hybridization was negative. HCMV DNA was detected in the maternal sera of five out of 21 pairs of seroconversions and in two cases on the first negative serum. The assay was also carried out on 50 of the 64 HCMV IgM positive sera. Two had detectable HCMV DNA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8890034     DOI: 10.1002/(SICI)1096-9071(199609)50:1<9::AID-JMV3>3.0.CO;2-5

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  14 in total

1.  Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects.

Authors:  T Lazzarotto; P Spezzacatena; P Pradelli; D A Abate; S Varani; M P Landini
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  Evaluation of a cytomegalovirus glycoprotein B recombinant enzyme immunoassay to discriminate between a recent and a past infection.

Authors:  M J Sipewa; P Goubau; M Bodéus
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

3.  Anticytomegalovirus (anti-CMV) immunoglobulin G avidity in identification of pregnant women at risk of transmitting congenital CMV infection.

Authors:  T Lazzarotto; P Spezzacatena; S Varani; L Gabrielli; P Pradelli; B Guerra; M P Landini
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

4.  Multicenter evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin G avidity.

Authors:  M Baccard-Longere; F Freymuth; D Cointe; J M Seigneurin; L Grangeot-Keros
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

5.  Prenatal diagnosis of congenital human cytomegalovirus infection in amniotic fluid by nucleic acid sequence-based amplification assay.

Authors:  M Grazia Revello; Daniele Lilleri; Maurizio Zavattoni; Milena Furione; Jaap Middeldorp; Giuseppe Gerna
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

6.  Development and application of a PCR-based method including an internal control for diagnosis of congenital cytomegalovirus infection.

Authors:  R N Jones; M L Neale; B Beattie; D Westmoreland; J D Fox
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

7.  Cytomegalovirus infection in pregnancy: review of the literature.

Authors:  Silvia Bonalumi; Angelica Trapanese; Angelo Santamaria; Laura D'Emidio; Luisa Mobili
Journal:  J Prenat Med       Date:  2011-01

8.  Real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples from mothers with primary infection.

Authors:  S Gouarin; E Gault; A Vabret; D Cointe; F Rozenberg; L Grangeot-Keros; P Barjot; A Garbarg-Chenon; P Lebon; F Freymuth
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

9.  Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay.

Authors:  T Lazzarotto; C Galli; R Pulvirenti; R Rescaldani; R Vezzo; A La Gioia; C Martinelli; S La Rocca; G Agresti; L Grillner; M Nordin; M van Ranst; B Combs; G T Maine; M P Landini
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

10.  Analysis of mumps vaccine failure by means of avidity testing for mumps virus-specific immunoglobulin G.

Authors:  M Narita; Y Matsuzono; Y Takekoshi; S Yamada; O Itakura; M Kubota; H Kikuta; T Togashi
Journal:  Clin Diagn Lab Immunol       Date:  1998-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.